MedPath

NEO-LAX TAB

NEO-LAX TAB

Discontinued
DIN Number

00661635

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

golden neo-life international ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00661635
AIG Number0734869001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:01.00*
Health Canada Classification

ACTIVE INGREDIENTS (7)

ALDER BUCKTHORNActive
Strength: 80 MG / TAB
Monograph: ALDER BUCKTHORN
ASPARAGUS OFFICINALISActive
Strength: 15 MG / TAB
Monograph: ASPARAGUS OFFICINALIS
BLACKROOTActive
Strength: 6 MG / TAB
Monograph: BLACKROOT
GLYCYRRHIZA GLABRAActive
Strength: 40 MG / TAB
Monograph: GLYCYRRHIZA GLABRA
PRUNEActive
Strength: 35 MG / TAB
Monograph: PRUNE
RHUBARBActive
Strength: 15 MG / TAB
Monograph: RHUBARB
SENNAActive
Strength: 120 MG / TAB
Monograph: SENNA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.